These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 29805720)
1. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis. Frantz C; Pezet S; Avouac J; Allanore Y Dis Markers; 2018; 2018():8509583. PubMed ID: 29805720 [TBL] [Abstract][Full Text] [Related]
2. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble CD163 in patients with systemic sclerosis. Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Ihn H Rheumatol Int; 2012 Feb; 32(2):403-7. PubMed ID: 21120485 [TBL] [Abstract][Full Text] [Related]
4. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis. Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944 [TBL] [Abstract][Full Text] [Related]
5. Increased serum levels of soluble CD163 in patients with scleroderma. Shimizu K; Ogawa F; Yoshizaki A; Akiyama Y; Kuwatsuka Y; Okazaki S; Tomita H; Takenaka M; Sato S Clin Rheumatol; 2012 Jul; 31(7):1059-64. PubMed ID: 22453843 [TBL] [Abstract][Full Text] [Related]
6. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis. Elger T; Fererberger T; Huss M; Sommersberger S; Mester P; Stoeckert P; Gunawan S; Liebisch G; Loibl J; Kandulski A; Müller M; Buechler C; Tews HC Exp Mol Pathol; 2024 Jun; 137():104900. PubMed ID: 38729058 [TBL] [Abstract][Full Text] [Related]
7. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
8. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis. Suzuki Y; Shirai M; Asada K; Miwa S; Karayama M; Nakamura Y; Inui N; Shirai T; Hayakawa H; Baba S; Suda T Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD163 is a potential biomarker in systemic sclerosis. Matsushita T; Takehara K Expert Rev Mol Diagn; 2019 Mar; 19(3):197-199. PubMed ID: 30657715 [No Abstract] [Full Text] [Related]
10. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559 [TBL] [Abstract][Full Text] [Related]
11. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus. Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel. Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354 [TBL] [Abstract][Full Text] [Related]
17. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study. Dekkema GJ; Abdulahad WH; Bijma T; Moran SM; Ryan L; Little MA; Stegeman CA; Heeringa P; Sanders JF Nephrol Dial Transplant; 2019 Feb; 34(2):234-242. PubMed ID: 29506265 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Jude C; Dejica D; Samasca G; Balacescu L; Balacescu O Rheumatol Int; 2013 Apr; 33(4):1031-7. PubMed ID: 23011084 [TBL] [Abstract][Full Text] [Related]
19. Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury. Craig DG; Lee P; Pryde EA; Hayes PC; Simpson KJ Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1395-404. PubMed ID: 24138337 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients. Tanimura H; Mizuno K; Okamoto H Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]